Amy Krie
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
Papers in
-
- Cancer Genomics and Diagnostics 5
- Breast Cancer Treatment Studies 4
-
- Advanced Breast Cancer Therapies 4
- Co-authors
- Brian Leyland‐Jones (7 shared papers)Casey Williams (7 shared papers)Jason K. Sicklick (2 shared papers)Paul T. Fanta (2 shared papers)Michael E. Hahn (2 shared papers)J. Jack Lee (2 shared papers)Scott M. Lippman (2 shared papers)Razelle Kurzrock (2 shared papers)
- Journals
- Cancers (1 paper)Nature Medicine (1 paper)Journal of Clinical Oncology (1 paper)Molecular Case Studies (1 paper)The Breast Journal (1 paper)
- Partner nations
- United StatesNetherlandsIndia
In The Last Decade
Amy Krie
9 papers receiving 517 citations
Amy Krie's Hit Papers
Peers
Comparison fields: 5 of 64
- Cancer Research 268
- Oncology 257
- Pulmonary and Respiratory Medicine 172
- Pathology and Forensic Medicine 80
- Statistics and Probability 21
Countries citing papers authored by Amy Krie
This map shows the geographic impact of Amy Krie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Krie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Krie more than expected).
Fields of papers citing papers by Amy Krie
This network shows the impact of papers produced by Amy Krie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Krie. The network helps show where Amy Krie may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy Krie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study Hit paper breakdown → | 2019 | 429 |
| 2 | 2021 | 62 | |
| 3 | 2017 | 14 | |
| 4 | 2020 | 9 | |
| 5 | 2016 | 4 | |
| 6 | 2017 | 4 | |
| 7 | 2020 | 2 | |
| 8 | 2019 | 2 | |
| 9 | 2016 | 1 | |
| 10 | 2024 | 0 |
About Amy Krie
Amy Krie is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Pathology and Forensic Medicine and Genetics, having authored 10 papers that have together received 527 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (5 papers), Genetic factors in colorectal cancer (4 papers), Breast Cancer Treatment Studies (4 papers), Advanced Breast Cancer Therapies (4 papers), Colorectal Cancer Treatments and Studies (1 paper), Cancer Treatment and Pharmacology (1 paper), Genetic Associations and Epidemiology (1 paper) and Economic and Financial Impacts of Cancer (1 paper). The work is most often cited by research in Cancer Research (268 citations), Oncology (257 citations), Pulmonary and Respiratory Medicine (172 citations), Pathology and Forensic Medicine (80 citations) and Statistics and Probability (21 citations). Amy Krie has collaborated with scholars based in United States, Netherlands and India. Frequent co-authors include Brian Leyland‐Jones, Casey Williams, Jason K. Sicklick, Paul T. Fanta, Michael E. Hahn, J. Jack Lee, Scott M. Lippman, Razelle Kurzrock, Shumei Kato and Jeffrey S. Ross. Their work appears in journals such as Cancers, Nature Medicine, Journal of Clinical Oncology, Molecular Case Studies and The Breast Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.